TYPHIBEV
Sponsors
GlaxoSmithKline
Conditions
DiarrhoeaSalmonella Infections
Phase 2
A Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in Infants
CompletedNCT06663436
Start: 2024-11-13End: 2025-10-21Updated: 2026-01-30
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants
Not yet recruitingNCT07286370
Start: 2026-02-16End: 2028-04-27Target: 537Updated: 2026-01-21
Long-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children
Not yet recruitingNCT07320716
Start: 2026-01-02End: 2028-10-31Target: 528Updated: 2026-01-06